OAM
ELOS

Oberweis Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Oberweis Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17,800
Closed -$189K – 191
2015
Q2 		$189K Hold
17,800
– – 0.05% 163
2015
Q1 		$220K Buy
+17,800
New +$197K 0.06% 161

Other funds holding ELOS

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oberweis Asset Management's ELOS Position: Q3 2015 in Review

Oberweis Asset Management sold out of Syneron Medical Ltd (ELOS) in Q3 2015, closing a stake of 17,800 shares — an estimated $189K sold.

Oberweis Asset Management first reported a position in ELOS in Q1 2015 and held it in 2 quarters. The position peaked at $220K in Q1 2015. 66 funds tracked by Wall St. Rank hold ELOS as of Q3 2015.

  • Oberweis Asset Management reported no remaining Syneron Medical Ltd position as of Q3 2015 after selling out during the quarter.
  • Oberweis Asset Management sold 17,800 Syneron Medical Ltd shares in Q3 2015, an estimated $189K.
  • Oberweis Asset Management first reported a position in Syneron Medical Ltd in Q1 2015 and held it in 2 quarters.
  • Oberweis Asset Management's Syneron Medical Ltd position peaked at $220K in Q1 2015.
  • 66 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2015.

Based on Oberweis Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.